Use of hydrophilic particles associated with identical or different antigens for the preparation of vaccine compositions
FR2808194A1
Use of hydrophilic particles with or without ion ligands for improving the immunomodulator properties of a substance other than an antigen, and the pharmaceutical compositions thus obtained
FR2805269A1
New cationic polymers comprising polyhydroxylated backbone grafted with cationic ligands, are degradable in vivo at controlled rate and useful as carriers for e.g. drugs, vaccines or cosmetic agents
FR2803526A1
New stable polymeric matrices, useful e.g. for delivery, release and/or stabilization of drugs, comprising charged macromolecular hydrophilic matrix incorporating oppositely charged lipid phase
FR2794371A1
Polyepitopic protein fragments, their obtainment and their uses in particular in vaccination
FR2794368A1
New polyepitopic fragments from the p53 protein, useful for treatment or prevention of cancer, e.g. of breast or colon
FR2794370A1
Polyepitopic protein fragments, their obtainment and their uses in particular in vaccination
FR2787029A1
Use in a pharmaceutical composition for nasal administration of vitamin b12 for the delivery of active agents to the central nervous system
FR2771929A1
Use in a pharmaceutical composition for the nasal delivery of hydrophilic particles for the delivery of active agents to the central nervous system
FR2766705A1
Particle complex of neutral or negative global charge formed of a cationic or neutral vesicle and a biologically active anionic substance, their preparation and their use
